AVIDITY BIOSCIENCES INC's ticker is RNA and the CUSIP is 05370A108. A total of 95 filers reported holding AVIDITY BIOSCIENCES INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $51,761 | -47.7% | 8,113 | -9.0% | 0.03% | -47.5% |
| Q2 2023 | $98,923 | +8.7% | 8,920 | +50.4% | 0.06% | +18.0% |
| Q1 2023 | $91,041 | -50.1% | 5,931 | -27.8% | 0.05% | -47.4% |
| Q4 2022 | $182,291 | +25.7% | 8,215 | -7.2% | 0.10% | +63.8% |
| Q3 2022 | $145,000 | +13.3% | 8,852 | +0.8% | 0.06% | +23.4% |
| Q2 2022 | $128,000 | +10.3% | 8,781 | +39.7% | 0.05% | -9.6% |
| Q1 2022 | $116,000 | -26.6% | 6,286 | -5.7% | 0.05% | -13.3% |
| Q4 2021 | $158,000 | -21.8% | 6,664 | -18.6% | 0.06% | -32.6% |
| Q3 2021 | $202,000 | -5.2% | 8,189 | -4.9% | 0.09% | +1.1% |
| Q2 2021 | $213,000 | +7.0% | 8,613 | -5.7% | 0.09% | +4.8% |
| Q1 2021 | $199,000 | -13.1% | 9,138 | +1.9% | 0.08% | -11.6% |
| Q4 2020 | $229,000 | – | 8,972 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,571,160 | $40,096,000 | 20.10% |
| Aaron Wealth Advisors LLC | 524,239 | $13,378,000 | 4.90% |
| Octagon Capital Advisors LP | 430,041 | $10,975,000 | 3.80% |
| EcoR1 Capital, LLC | 2,103,950 | $53,693,000 | 2.89% |
| RTW INVESTMENTS, LP | 3,995,000 | $101,952,000 | 1.71% |
| ACUTA CAPITAL PARTNERS, LLC | 246,200 | $6,283,000 | 1.71% |
| Cormorant Asset Management, LP | 2,464,547 | $62,895,000 | 1.50% |
| Logos Global Management LP | 671,454 | $17,136,000 | 1.47% |
| Boxer Capital, LLC | 1,121,327 | $28,616,000 | 0.92% |
| HighVista Strategies LLC | 26,665 | $680,000 | 0.43% |